The Promise of Neuroprotective Agents in Parkinson’s Disease
Parkinson’s disease (PD) is characterized by loss of dopamine neurons in the substantia nigra of the brain. Since there are limited treatment options for PD, neuroprotective agents are currently being tested as a means to slow disease progression. Agents targeting oxidative stress, mitochondrial dys...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Research Foundation
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221408/ |